期刊文献+

骨形成蛋白-4对于肺动脉高压患者肺血管重构作用的研究进展 被引量:1

Research progress of bone morphogenetic protein-4 in pulmonary vascular remodeling in patients with pulmonary hypertension
原文传递
导出
摘要 肺动脉高压是一大类以肺动脉压力增高,伴或不伴小肺动脉病变为特征的肺血管疾病,其最终可导致患者右心功能衰竭甚至死亡,肺动脉高压已成为威胁人类身心健康的严重疾病。肺动脉高压发病机制多种多样,目前尚无确切定论,但是对遗传性肺动脉高压的研究发现,骨形成蛋白信号系统参与了肺动脉高压的发生发展。本文将对骨形成蛋白-4(BMP4)在肺动脉高压发生发展中的作用以及相关研究进展进行简要综述。 Pulmonary hypertension is a disease characterized by pulmonary artery pressure increased,with or without small artery pathological change,which ultimately leads to right heart failure or even death.Pulmonary hypertension seriously threatens to human health,however,the pathogenesis of pulmonary hypertension is unclear.Previous studies have found that bone morphogenetic protein(BMP)signaling system played an important role in the progress of pulmonary hypertension.In the current review,we describe the mechanism of BMP4 in the development of pulmonary hypertension.
作者 钱宏 胡佳 QIAN Hong;HU Jia(Department of Cardiovascular Surgery,West China Hospital,Sichuan University,Chengdu,610041,P.R.China)
出处 《中国胸心血管外科临床杂志》 CAS CSCD 2019年第3期274-277,共4页 Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
基金 国家自然科学基金(81670327 81300155)
关键词 肺动脉高压 骨形态蛋白 肺血管重构 Pulmonary hypertension bone morphogenetic protein pulmonary vascular remodeling
  • 相关文献

参考文献2

二级参考文献24

  • 1Humbert M, Sithon (), Simonneau G. Treatment of pulmonary arterial hyi:mrtension. N Engl J Med, 2004 ; 351 ( 14 ) : 1425 1436.
  • 2Farah P, Ahmad AA, Mohammad B, el al. Oral sildenafil to control puhnonary hypertension after congenital heart surgery. Asian Cardiovasc Thorac Ann, 2007 ; 15(2) : 113-117.
  • 3Mehrotra N, Copta M, Kovar A, et al. The role of pharmacokinetics and pharmacodynamics in phosphodiesterase-5 inhibitor therapy, Int J Imoot Res,2007;19(3):253-264.
  • 4Ghofrani HA, Osterloh IH, Grimminger F. Sildenafil.- from angina to erectile dysfunction to pulmonary hypertension and beyond. Drug Discovery,2006 ;5(8) ;689-702.
  • 5Gross GJ. Sildenafil and endothelial dysfunction in humans. Circulation,2005;111 (6) :721-723.
  • 6Galie N, Ghofrani HA, Torbicki A, et al. Sildenafil chrate therapy for pulmonary arterial hypertension. N Engl J Med, 2005;353(20):2148-2157.
  • 7无.肺动脉高压筛查诊断与治疗专家共识[J].中华心血管病杂志,2007,35(11):979-987. 被引量:271
  • 8Giuseppe GP, Frederique C, Susan S, et al. Pathologic assessment of vasculopathies in pulmonary hypertension [ J ]. J Am Coil Cardiol, 2004, 43( 12 Suppls): 25s-32s.
  • 9Tuder RM, Stacher E, Robinson J, et al. Pathology of pulmonary hypertension[ J ]. Clin Chest Med, 2013, 34(4 ): 639-650.
  • 10Tuder RM, Groves B, Badesch DB, et ah Exuberant indothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension[ J ]. Am J Pathol, 1994, 144(2 ): 275-285.

共引文献3

同被引文献3

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部